IN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million
26 Maggio 2021 - 10:28PM
Alliance News
IM cash shell
which acquired BiVictriX Therapeutics Ltd for GBP5.5 million -
Proposes name change to BiVictriX Therape ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Apr 2023 a Apr 2024
Notizie in Tempo Reale relative a Motif Bio Plc (Borsa di Londra): 0 articoli recenti
Più Articoli Notizie